13F

Stock

Lisata Therapeutics, Inc.

LSTA · held by 26 managers

Reported value

$1.36M

Holders

26

+0 new · −1 exited

Holders’ est. mark

−$7.97K

Price effect on 2 books still in the name

Largest holder

$503.9K

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard270.9K$503.9KHeld
Renaissance Technologies123.7K$230.1KHeld
BML Capital Management, LLC73.3K$136.4KHeld
GEODE CAPITAL MANAGEMENT, LLC64.4K$119.9KHeld
BlackRock, Inc.54.9K$102KHeld
Ground Swell Capital, LLC39K$72.5KHeld
Cerity Partners LLC12.2K$49.1KHeld
State Street14.3K$26.7KHeld
DIMENSIONAL FUND ADVISORS LP14.3K$26.5KHeld
BANK OF AMERICA CORP /DE/10.4K$19.4K−$7.92KCut−$7.92K
NORTHERN TRUST CORP10.3K$19.1KHeld
HighTower Advisors, LLC10K$18.7KHeld
ROYAL BANK OF CANADA5.91K$11KHeld
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC5K$9.3KHeld
Tower Research Capital LLC (TRC)2.55K$4.75KHeld
Founders Capital Management1.67K$3.1KHeld
Connective Capital Management, LLC1.02K$1.89KHeld
UBS Group AG871$1.62KHeld
NewEdge Advisors, LLC107$199Held
OSAIC HOLDINGS, INC.100$186Held
MORGAN STANLEY75$140−$57Cut−$405
Cheviot Value Management, LLC3$14Held
SBI Securities Co., Ltd.7$13Held
CITIGROUP INC1$2Held
Fortitude Family Office, LLC1$2Held
Fidelity0$0Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.